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Objective: To verify that Proliverenol has a potential ability in protecting cells from
ethanol-induced hepatotoxicity.
Methods: Activity of Proliverenol against ethanol-induced apoptosis was evaluated at
mRNA and protein levels in HepG2 cell exposed to Proliverenol for 1 and 3 h.
Results: Proliverenol conferred hepatoprotective activity through increasing cell survival
up to 53%–69% via up-regulation of APEX1 DNA repair enzyme for 3.0–4.7 fold and
down-regulating of nuclear factor-kB, tumor necrosis factora and caspase-8 expression,
allowing them to prevent 4.5–6.9 fold of alanine aminotransferase (ALT) leakage in
HepG2 cells. Our ﬁnding revealed that Proliverenol repressed expression of ALT, which is
signiﬁcantly important as possible alternative mechanism for increased blood transaminase
activities. In addition, the result also showed that caspase-8 pathway seemed to be involved
in the molecular pathway rather than directly inducing mitochondrial damage.
Conclusions: The data support our hypothesis that Proliverenol has a potential ability in
protecting cells from ethanol-induced hepatotoxicity. We propose that Proliverenol pro-
vides hepatoprotective activity through up-regulating expression of APEX1 that repress
DNA fragmentation, and down-regulating expression of nuclear factor-kB, tumor ne-
crosis factora and caspase-8, which therefore repress ALT leakage and its expression.1. Introduction
Liver is considered as one of themost vital organs that act as the
center of metabolism of nutrients and excretion of waste products.
Its function includes detoxiﬁcation, protein synthesis, and pro-
duction of biochemical compounds for digestion as well as syn-
thesis and breakdown of small and complex molecules. These
activities are necessary for normal body functions. Injury to liver
cells is induced by various toxic chemicals such as antibiotics,
chemotherapeutic agents, carbon tetrachloride, thioacetamide, D-
galactosamine/lipopolysaccharide, microbes, and consumed
alcohol [1–5]. Excessive alcohol consumption is known as the
major common cause for liver disease. Despite much effort hasbeen addressed to understand alcoholic liver disease in the past
decades, there remains no effective therapy fot the disease [6].
This limitation gives considerable interest to search for useful,
safe and effective hepatoprotectors of herbal origin.
Nowadays, herbal drugs have become increasingly popular in
the treatment of liver diseases. In vitro cytotoxicity of plant ex-
tracts and bioassay guided fractions have also gained importance
for drugs primary level screening. Several plant and fungi ex-
tracts have been reported to possess therapeutic properties to treat
liver disease, i.e. Sida cordifolia [7], Adina cordifolia [8], Feronia
limmonia [9], Silybum marianum [10], Trigonella foenum [11],
Phyllantus emblica, Camellia sinensis, Mangifera indica, and
Punica granatum [12]. These extracts showed different
mechanisms in providing hepatoprotective effect. However,
exploring the anti-oxidant activity of extracts through the mito-
chondrial pathway is the most adapted approach.
Proliverenol is a standardized bioactive fraction of Phaleria
macrocarpa (Scheff.) Boerl (P. macrocarpa). In this study, we
evaluated the effect of Proliverenol as a hepatoprotector in
HepG2, a human hepatoma cell lines and reported here the
molecular mechanism by which Proliverenol exerts its hep-
atoprotective action in the cultured hepatoma cells.article under the CC BY-NC-ND license (http://
Guntur Berlian et al./Asian Pac J Trop Biomed 2016; 6(8): 686–691 6872. Materials and methods
2.1. Preparation of Proliverenol
Proliverenol was bioactive fraction extracted from
P. macrocarpa fruit. The P. macrocarpa fruit originated from
Central Java, Indonesia. The plant has been identiﬁed by the
Herbarium Bogoriense, Research Center of Biology, Indonesian
Institute of Sciences with certiﬁcate No. 1261/IPH.1.02/If.8/XII/
2009. Slices of P. macrocarpa fruit were macerated using water
based solvent. The extract was ﬁltrated, concentrated, dried in a
conventional oven and then stored in a well closed container.
Identiﬁcation of Proliverenol was done on a thin layer
chromatography plate silica gel 60 F254 using ethyl acetate:
aceton: formic acid: water (8:2:1:1, v/v) as the eluent. The re-
agent was purchased from Merck (Darmstadt, Germany). The
eluent was allowed to migrate on the thin layer chromatography
plate for 8 cm. The chromatogram was then observed under UV
(l = 254 nm), in which before derivatization, black band
appeared at the Rf ± 0.6 and Rf ± 0.8; while after derivatization
by 10% H2SO4 in water, yellow and brownish yellow bands
appeared at the Rf ± 0.6 and Rf ± 0.8, respectively. The marker
compound (band at Rf ± 0.6) was quantiﬁed in Proliverenol
using high-pressure liquid chromatography Waters® under UV
(l = 254 nm), in an Agilent ZORBAX Extend-C18
(4.6 mm × 250 mm, 5 mm) as a column and acetonitrile and
acetic acid (pH 3.3) as mobile phase. The content of the marker
compound was not less than 2.5% in Proliverenol.
2.2. Cell culture and activity of Proliverenol
HepG2 cells purchased from ATCC (Virginia, USA) were
grown in minimum essential medium-a medium supplemented
with 10% newborn calf serum (Gibco, Grand Island, USA),
100 mg/mL penicillin-streptomycin (Gibco, Grand Island, USA),
and 1 mmol/L sodium bicarbonate (Gibco, Grand Island, USA)
at 37 C until 80% of conﬂuence was reached. Cells were sub-
cultured in 6-well plates in 2 mL medium or 10 cm Petri dish in
10 mL medium. After 3–5 days (about 80% of conﬂuence), the
medium were aspirated and replenished with the serum-free
medium for 4 h. The cells were treated with 5% absolute
ethanol and then supplemented with 168 mg/mL of Proliverenol
for 1 and 3 h. RNA of the control and treated-HepG2 cells was
isolated by Trizol Reagent (Invitrogen, CA, USA), and was
reverse-transcribed to obtain the cDNA. The protein was iso-
lated with lysis buffer-protease inhibitor complex (Calbiochem,
Darmstadt, Germany). The cDNA was used as the template for
ampliﬁcation of gene fragment using PCR and real-time PCR
techniques, and the protein was used to measure protein
expression by western blotting. The primers used are alanine
transferase (ALT) forward, 50-CTTGCCTGCAGTTCCCTCTG-
30; ALT reverse, 50-GCTCGAGGCCATGACTCTAC-30;
APEX1 forward, 50-ATCTCGCGAGCAACGCGGTA; APEX1
reverse, 50-GAAAGCAGGCCCACCCCACT-30. All primers
were synthesized by First BASE Laboratories (Singapore).
2.3. ALT assay
ALT production of the cells was assayed using ALT assay kit
from Abcam (Cambridge, UK). HepG2 cells at a concentration of
1 × 106 cells per well were homogenized in 200 mL ice-cold ALTassay buffer, and then centrifuged 13000 r/min for 10 min to
remove insoluble material. The positive control, standard or sam-
ples were then mixed with ALT reaction mix (ALT assay buffer,
OxiRed probe, ALT enzyme mix and ALT substrate) and the
absorbance was measured at 570 nm (A1) at T1 (T1 > 10 min) then
again (A2) at T2 after incubating the reaction at 37 C which
occurred after initial lag phase. Optical density of the color
generated by oxidation of pyruvate was calculated using equation
A2–A1.
2.4. Caspase-8 assay
Caspase-8 of the cells was assayed using caspase-8 human
assay kit from Abcam (Cambridge, UK). HepG2 cells at a
concentration of 5 × 106 cells per well were harvested and
lysed with lysis buffer for 1 h at room temperature with gentle
shaking and then centrifuged at 4000 r/min for 15 min. Each
50 mL of sample diluent, samples and detection antibody were
loaded into the wells. After incubation at room temperature for
2 h, the liquid was removed and wells were washed using the
washing buffer. Anti-rabbit IgG-HRP (100 mL) was added to
the wells, which was then incubated for 1 h at room tempera-
ture and washed again. 3,30,5,50-Tetramethylbenzidine sub-
strate (100 mL) was added into all wells, and incubated for
15 min at room temperature. The reaction was stopped by
adding 100 mL stop solution. The absorbance was then
measured at 450 nm.
2.5. Cell cycle analysis
HepG2 cells at a concentration of 1 × 104 were harvested by
centrifugation for 5 min at 2500 r/min, and ﬁxed overnight in
absolute ethanol at 4 C. The cells were then stained with 1 mL
propidium iodide complex [10 mg/mL RNase, 20% NP40,
10 mg/mL propidium iodide (Merck, Darmstadt, Germany)] for
30 min in the dark room. Cell population was measured using
FACSCalibur (BD Biosciences) and further analyzed using
CellQuest Software (BD Biosciences).
2.6. DNA fragmentation assay
DNA fragmentation of the cells was assayed using apoptotic
DNA ladder detection kit from Roche Applied Science (Illinois,
USA). HepG2 cells at a concentration of 5 × 105 were harvested
by centrifugation for 5 min at 2500 r/min. Cell pellet was sus-
pended with 200 mL phosphate-buffered saline and then mixed
with 200 mL of lysis buffer prior to incubation for 10 min at
room temperature. Isopropanol (100 mL) was added into the
tubes and the mixture was vortexed. The liquid was transferred
into ﬁlter tube and centrifuged at 8000 r/min for 1 min and the
supernatant was then removed. The DNA was washed with
500 mL of washing buffer. Liquid was re-transferred into a new
tube and mixed with 200 mL of elution buffer. DNA fragmen-
tation was evaluated by electrophoresis.
2.7. Anti-oxidant activity of Proliverenol
Anti-oxidant activity of Proliverenol was evaluated using
2,2-diphenyl-1-picrylhydrazyl (DPPH) assay (Sigma, MO,
USA). Proliverenol was mixed with DPPH in a volumetric ﬂask,
and incubated for 30 min at room temperature. The percentage
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UV/vis at the absorbance of 517 nm. Ascorbic acid (8.9 mg/mL)
was used as positive control.
2.8. Lipid peroxidation assay
Lipid peroxidase activity of the cells was assayed using lipid
peroxidation [(malondialdehyde) MDA] assay kit from Abcam
(Cambridge, UK). HepG2 cells at concentration of 1 × 106 were
homogenized on ice in 300 mL MDA lysis buffer containing
3 mL butylated hydroxytoluene, and then centrifuged at 14000 r/
min for 10 min to remove insoluble material. The supernatant
(200 mL) from each homogenized sample was placed in a
microtube. Series of standard solution or samples were added
with 600 mL of thiobarbituric acid solution, incubated at 95 C
for 60 min, and cooled to room temperature in an ice bath for
10 min. Series of standard solution or samples (200 mL)
were-transferred to a 96-well microplate for analysis and the
absorbance was read at 520 nm.
2.9. Reactive oxygen species (ROS) assay
ROS of the cells was measured using human ELISA kit from
Cusabio (Hubei, China). HepG2 cells at a concentration of
1 × 107 were stored overnight at −20 C and freeze-thawed twoFigure 1. Proliverenol down-regulates ALT expression in ethanol-induced hepatotoxicity in HepG2 cells.
A: ALT mRNA expression level was analyzed using PCR; B: Real-time PCR analysis was performed to monitor the ALT mRNA expression level using
commercially available SYBR green dye. ALT mRNA was normalized using b-actin; C: ALT protein expression level in the media was analyzed using ALT
assay kit. E1h: EtOH treatment for 1 h; E + P1h: EtOH + Proliverenol treatment for 1 h; E3h: EtOH treatment for 3 h; E + P3h: EtOH + Proliverenol
treatment for 3 h. Values are mean ± SD of three samples. *: P < 0.05 versus control. GAPDH: Glyceraldehyde 3-phosphate dehydrogenase.times to break up the cell membranes. The cell lysates were
centrifuged for 5 min at 9000 r/min and the supernatant was
collected. Standard solution or samples (100 mL) were trans-
ferred into the wells and incubated for 2 h at 37 C. The liquid
was then removed from each well. Biotin antibodies (100 mL)
were added to the wells for 1 h at 37 C and mixed gently.
Liquid was removed and the wells were washed three times with
200 mL washing buffer. HRP-avidin (100 mL) was added into
each well and the mixture was incubated for 1 h at 37 C, and
then washed again with the washing buffer. Finally, 3,30,5,50-
tetramethylbenzidine substrate (90 mL) was added and further
incubated for 30 min at 37 C. The reaction was then stopped byadding 50 mL of stop solutions. Optical density of each well was
measured within 5 min using a microplate reader at 450 nm.
2.10. Statistical analysis
The statistical differences between the test and control sam-
ples were determined by student's t-test using the Stat View
software package (Abacus Concepts, Piscataway, NJ, USA).
Values were expressed as means ± SD for at least two inde-
pendent experiments (P < 0.05).
3. Results
3.1. Production of liver enzyme downregulated by
Proliverenol
In this study, ethanol treatment was found to induce liver
cellular damage and cell death in HepG2 cells. ALT has become
the most important marker of hepatotoxicity condition across
species [13–16]. The result showed that treatment with 5% ethanol
increased ALT production in HepG2 cells while application of
Proliverenol decreased ALT expression (Figure 1). This result
suggested that Proliverenol affected ALT expression at both
mRNA (1.3–2.3 fold) and protein (4.5–6.8 fold) levels.3.2. Ethanol-mediatedapoptosis prevented byProliverenol
through down-regulating nuclear factor-kB (NF-kB)
pathway
Many regulators are involved in the inﬂammation-ﬁbrosis-
cancer process, and NF-kB pathway appears to have a central
function in liver homeostasis [17]. This pathway also involves
another signaling molecule, tumor necrosis factora (TNFa),
which initiates cell death processes. Our present study showed
that Proliverenol could decrease expression of NF-kB and
TNFa that was previously increased by ethanol induction
(Figure 2A).
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Figure 2. Proliverenol prevents ethanol-mediated apoptosis by down-regulating Fas-NF-kB pathway in HepG2 cells.
A: Down-regulation of NF-kB and TNFa. Intracellular protein was prepared and subjected to western blot analysis to determine NF-kB and TNFa expression
level. b-actin was used as an internal control; B: Down-regulation of caspase-8. Values are mean ± SD of three samples. *: P < 0.05 versus control.
Table 1
Proliverenol prevents ethanol-mediated apoptosis by decreasing sub-G1
phase in HepG2 cells.
Treatment Phases (%)
Sub-G1 G0/G1 S G2/M
Control 9.45 50.53 9.25 30.76
EtOH 1 h 26.13 36.78 12.99 24.10
EtOH + Proliverenol 1 h 12.17 47.10 10.69 30.05
EtOH 3 h 29.86 37.71 9.67 22.77
EtOH + Proliverenol 3 h 9.08 45.70 11.46 33.76
Guntur Berlian et al./Asian Pac J Trop Biomed 2016; 6(8): 686–691 689Involvement of caspase-8 and caspase-9 in prevention of
ethanol-mediated cell death by Proliverenol was evaluated. West-
ern blotting analysis of these two caspases showed that caspase-8
seemed to be signiﬁcantly more involved in the processes rather
than caspase-9 (data not shown). The result is in agreement with
previous report on the ethanol-induced hepatotoxicity conditions
leading to cell death through caspase-8 activity [1].
Furthermore, production of caspase-8 was also analyzed in the
control and ethanol-Proliverenol-treated cells. The result showed
that 5% ethanol treatment increased caspase-8 production in
HepG2 cells and supplementation of 168 mg/mL of Proliverenol
decreased its synthesis. This is in agreement with Proliverenol
preventing apoptosis resulting from ethanol treatment through
repression of caspase-8 production (Figure 2B).
Effect of Proliverenol on the cell cycle proﬁle was evaluated
using ﬂow cytometer. The result showed that ethanol treatment
(5%) for 1 and 3 h increased the cell cycle arrest and sub-G1
phase of the cell, which may explain occurrence of apoptosis.
Supplementation of 168 mg/mL of Proliverenol decreased sub-
G1 phase percentage from 53.4% to 69.6% (Table 1). This result
conﬁrmed that application of Proliverenol had led to protection
of the cell against toxic effect of the ethanol.A
B
C
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Figure 3. Proliverenol represses DNA fragmentation by increasing APEX1 ge
A: Proliverenol represses DNA fragmentation induced by ethanol treatment; B: A
analysis was performed to monitor APEX1 mRNA expression level using com
GAPDH. Values are mean ± SD of three samples. *: P < 0.05 versus control.3.3. DNA fragmentation repressed by Proliverenol
through increasing APEX1 gene expression
Hepatic damage as shown by elevation of serum amino-
transferase production was correlated with DNA fragmentation
[18]. Occurrence of DNA fragmentation in this research was
shown in the electrophoresis result. Existence of fragments
other than HepG2 genome indicated that the DNA was
fragmented by 5% alcohol treatment. The result conﬁrmed that
Proliverenol repressed DNA fragmentation induced by 5%
ethanol in HepG2 cells (Figure 3A). Interestingly, the resultDNA genome
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Guntur Berlian et al./Asian Pac J Trop Biomed 2016; 6(8): 686–691690also showed that ethanol-induced DNA fragmentation repeat-
edly produced two fragments of ~400 and ~600 bp. We hy-
pothesized that ethanol had a speciﬁc target on fragmenting the
HepG2 DNA genome.
Our previous experiment also clearly showed that expression
of APEX1, an enzyme important for hepatoprotection by
repairing the destructed DNA, was decreased by 5% ethanol. In
contrast, treatment of Proliverenol for 1 h increased the
expression of APEX1 (Figure 3B, C). This result suggested that
Proliverenol may serve as hepatoprotector through up-regulation
of APEX1 expression.
3.4. Anti-oxidant properties of Proliverenol
The ability of most herbal drugs in protecting liver cells was
related to their anti-oxidant activities, which further improved
hepatoprotection through mitochondrial pathway [5,10,19–21]. Our
experiment demonstrated that Proliverenol had strong anti-
oxidant activity (Figure 4) thereby capable to protect the cells.
Interestingly, the result described that both ethanol and Proli-
verenol treatments did not signiﬁcantly affect lipid peroxidation
and ROS activities (Figure 5A, B). This result indicated that
hepatoprotective activity of Proliverenol in HepG2 cells may not
be through mitochondrial pathway (lipid peroxidase, ROS and
caspase-9).100
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Figure 4. Anti-oxidant activity of Proliverenol compared to ascorbic acid.
Anti-oxidant activity was studied with stable free radical DPPH. Values are
mean ± SD of three samples. *: P < 0.05 versus control.
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Figure 5. Effect of Proliverenol in ethanol-induced hepatotoxicity in HepG2 cells.
A: Lipid peroxidation measured by 2-thiobarbituric acid reactive substances assay and expressed as MDA level; B: ROS production. Values are mean ± SD
of three samples. LPO: Lipid peroxidation.4. Discussion
Liver has enormous regenerative capacity, but regeneration of
the cells is lost by apoptotic cell death.Active proliferative responseof the liver cells makes the organ as an important target of carcin-
ogens [22–24]. Hepatotoxicity induced by several agents: ethanol,
carbon tetrachloride, thioacetamide, adenosine and tert-butyl
hydroperoxide [1,3,5,12,19,25] and the different pathways of hepato-
toxicity have been reported [26].
Hepatotoxicity is associated with massive fragmentation of
DNA of the liver cell, which further triggers apoptotic cascade
in the liver cells [18,21,27]. The apoptotic cascade is related to
several regulators, i.e. NF-kB and TNFa [7,23,25]. NF-kB is a
central regulator of cellular stress in all cell types of the liver.
Activation of NF-kB in the liver starts the transcription of
genes involved in the cell cycle arrest and apoptosis [17]. On
the other hand, TNFa plays a critical role in the initiation of
apoptotic cascade and development of alcoholic diseases
[2,28,29]. In this experiment, we found that ethanol-treated-
HepG2 cells induced hepatocellular damage via DNA
fragmentation, increased expression of NF-kB and TNFa at
the protein level and transaminase enzymes leakage as the
consequence of the cell death. Ethanol-induced stress condi-
tion leads to activation of NF-kB, which further accounts for
increase of the pro-inﬂammatory cytokine TNFa. This cytokine
then stimulates the cells to undergo apoptosis. Chronic alcohol
administration was reported to increase intrahepatic mRNA
level of TNFa, likely originated from increased activation of
NF-kB [2,7].
In our experiment, Proliverenol was shown to block the
ethanol-induced DNA fragmentation through up-regulation of
APEX1 expression. This enzyme plays signiﬁcant role in hep-
atoprotection by repairing the damaged DNA. Proliverenol ap-
pears to positively improve the DNA repair system, which
therefore blocks the fragmentation, and subsequently decreases
the apoptotic cascade of NF-kB and TNFa. Similar researches
have also reported that DNA fragmentation in liver was
repressed by hepatoprotective of Ganoderma tsugae in rat's liver
[21] and gentiopicroside activity in mice [4].
Ethanol induced hepatotoxicity and cell death through
various pathways [1,23,30]. Ethanol concentrations and incubation
period could become factors that determine the pathways
involved [1]. In this study, 5% ethanol treatment for 1 and 3 h
was used to induce cell death. This treatment appears to affecta speciﬁc pathway of the cell death that involves caspase-8.
Thus, our result reveals that this pathway is involved in the
ethanol-induced hepatotoxicity condition instead of the mito-
chondrial pathway (lipid peroxidase, ROS, caspase-9).
Guntur Berlian et al./Asian Pac J Trop Biomed 2016; 6(8): 686–691 691Our ﬁnding also suggests important evidences that Proliver-
enolmodulates decreasing amount of transaminase enzymes, such
asALT. Proliverenol appears to repressALT expression atmRNA
level and the protein leakage from cytoplasm into the culture
medium. As ALT is the most commonly used clinical marker of
hepatotoxicity, the result describes that Proliverenol positively
provides potential cytoprotection on liver cells from hepatotox-
icity and underlines the importance of gene regulation as possible
alternative mechanism for increased blood transaminase.
In conclusion, the data obtained in the present study support
our hypothesis that Proliverenol has a potential ability in pro-
tecting cells from ethanol-induced hepatotoxicity. We proposed
that Proliverenol provides hepatoprotective activity through up-
regulating APEX1 that repress DNA fragmentation, and down-
regulation of NF-kB, TNFa and caspase-8, which therefore
repress ALT leakage and its expression.
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